MedPacto, Inc. (KOSDAQ:235980)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,145.00
-45.00 (-1.41%)
Jun 30, 2026, 3:30 PM KST
Market Cap107.80B -13.5%
Revenue (ttm)4.79B +1,012.9%
Net Income-13.21B
EPS-383.85
Shares Out 34.28M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume88,601
Open3,190.00
Previous Close3,190.00
Day's Range3,045.00 - 3,300.00
52-Week Range2,655.00 - 8,650.00
Beta0.15
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About MedPacto

MedPacto, Inc. engages in the development and sale of marker-based new drugs in South Korea. MedPacto, Inc. was established in 2013 and is based in Seoul, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 235980
Full Company Profile

Financial Performance

Financial Statements